Laboratorios Farmaceuticos Rovi SA
Closed
SectorHealthcare
58 0.52
Overview
Share price change
24h
Min
57.6
Max
58.4
Income | 80M 89M |
|---|---|
Sales | 39M 192M |
P/E Sector Avg | 16.085 57.002 |
EPS | 1.466 |
Dividend yield | 1.63 |
Profit margin | 46.582 |
Employees | 2,470 |
EBITDA | 83M 101M |
Dividend yield Sector Avg | 1.63% 2.22% |
|---|---|
Next Earnings | 5 lis 2026 |
Market Cap | 220M 3B |
|---|---|
Previous open | 57.48 |
Previous close | 58 |
News Sentiment
By Acuity
50%
50%
152 / 340 Ranking in Healthcare
Laboratorios Farmaceuticos Rovi SA Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Laboratorios Farmaceuticos Rovi SA Forecast
Sentiment
By Acuity
152 / 340 Ranking in Healthcare
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Laboratorios Farmaceuticos Rovi SA
Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa; and hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express, Fibrilin, and Sodium Heparin Rovi. It also provides contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, and sachets. Laboratorios Farmaceuticos Rovi, S.A. was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.